SCOTTSDALE, Ariz., May 29, 2013 /PRNewswire/ -- Healthcare Trust of America, Inc. (NYSE:HTA) ("HTA") announced today Globe Street published an interview with HTA's Chairman and CEO Scott D. Peters. The interview focused on several key trends in the current medical office market including (i) the impact of the Affordable Care Act, (ii) the benefit of owning real estate on a health system campus, and (iii) the importance of HTA's internal management platform in partnering with leading health systems.
About Healthcare Trust of America, Inc.Healthcare Trust of America, Inc. (NYSE:HTA), a publicly traded real estate investment trust, is a fully-integrated, leading owner of medical office buildings. HTA listed its shares of Class A common stock on the New York Stock Exchange on June 6, 2012. HTA is a full-service real estate company focused on acquiring, owning and operating high-quality medical office buildings that are predominantly located on or aligned with campuses of nationally or regionally recognized healthcare systems in the U.S. Since its formation in 2006, HTA has built a portfolio of properties that totals approximately $2.7 billion based on purchase price and is comprised of approximately 12.8 million square feet of gross leasable area located in 27 states. It operates its properties through regional offices in Scottsdale, Charleston, Atlanta, and Indianapolis.
For more information on Healthcare Trust of America, Inc., please visit www.htareit.com.FORWARD-LOOKING LANGUAGE This press release contains certain forward-looking statements. Forward-looking statements are based on current expectations, plans, estimates, assumptions and beliefs, including expectations, plans, estimates, assumptions and beliefs about HTA, stockholder value and earnings growth.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts